Idex CORP /DE/

IDEX Corporation announced record second quarter sales of $921 million and record orders exceeding $1 billion, with adjusted diluted EPS up 12% to $2.32, leading to raised full-year guidance.

IDEX Corporation shareholders re-elected four directors and ratified executive compensation and auditor appointments.

IDEX Corporation announced robust first-quarter 2026 financial results, exceeding expectations with significant sales and earnings growth, leading to an upward revision of full-year guidance.

IDEX Corporation announced the elimination of the Senior Vice President, Chief Strategy and Innovation Officer position, held by Roopa Unnikrishnan, effective February 28, 2026.

IDEX Corporation announced record fourth quarter and full year 2025 financial results, driven by strong order growth in its Health & Science Technologies segment, particularly from AI-related projects.

IDEX Corporation announced the appointment of Sean M. Gillen as its new Chief Financial Officer and the departure of its Chief Human Resources Officer, Melissa S. Flores.

IDEX Corporation announced a 6% increase in net sales and an 11% rise in diluted EPS for the second quarter of 2026, driven by strong performance in its Health & Science Technologies segment.

IDEX Corporation announced a 10% increase in reported net sales and an 8% rise in diluted EPS for Q3 2025, driven by acquisitions and organic growth, despite challenging macroeconomic conditions.

IDEX Corporation reported a 7% increase in net sales for Q2 2025, driven by acquisitions, while organic sales growth remained modest and diluted EPS declined due to higher interest and amortization costs.

IDEX Corporation's first quarter 2025 results show a net sales increase of 2% but a decrease of 21% in diluted earnings per share, impacted by acquisition-related costs and market conditions.

IDEX Corporation's third-quarter results show a slight increase in net sales but a significant decrease in net income, impacted by market softness and acquisition costs, while the company completed the acquisition of Mott Corporation.

IDEX Corporation's second quarter 2024 results show a decrease in net sales, but solid operating performance with strong price/cost and productivity.

IDEX Corporation achieved record net sales of $3,457.5 million in 2025, a 6% increase, driven by acquisitions and organic growth, while diluted EPS decreased by 3%.

IDEX Corporation's 2024 results show flat net sales and a decrease in diluted earnings per share, while the company completed the acquisition of Mott Corporation.

IDEX Corporation's 2023 annual report highlights a year of strong operating performance amidst volume declines, strategic acquisitions, and record free cash flow.

IDEX Corp CEO and President Eric D. Ashleman reported transactions involving company stock, including the acquisition of shares and the sale of a significant number of shares.

Director Stanfield Watts Paris acquired 805 restricted stock units in IDEX Corporation as part of an equity award.

Director Alejandro Quiroz was granted 805 restricted stock units in IDEX Corp, vesting in May 2027.

Director Katrina L. Helmkamp was granted 1,035 restricted stock units as part of an equity compensation award.

Director Lakecia N. Gunter was granted 805 restricted stock units as part of an equity compensation award.

Director Matthijs Glastra was granted 805 restricted stock units as part of an equity compensation award.

IDEX Corporation announces its 2026 Annual Meeting of Stockholders, outlining proposals for director elections, executive compensation, and auditor ratification, alongside detailed corporate governance and compensation practices.

IDEX Corporation announces its 2025 Annual Meeting to be held on May 8, 2025, featuring proposals including director elections, executive compensation approval, auditor ratification, and a stockholder proposal on hiring practices.

IDEX Corporation's upcoming annual meeting will address director elections, executive compensation, auditor ratification, and a stockholder proposal on hiring practices.

IDEX Corporation's upcoming annual meeting on May 7, 2024, will address director elections, executive compensation, an incentive award plan, auditor ratification, and a stockholder proposal.

IDEX Corporation's proxy statement details proposals for the 2024 Annual Meeting, including director elections, executive compensation, and approval of a new incentive award plan.

Vanguard Capital Management has reported a beneficial ownership of 7.53% in IDEX Corp's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 3,777,844 shares, representing 5.09% of IDEX Corp's common stock, as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G, reporting zero beneficial ownership in IDEX Corp following an internal realignment.

Wellington Management Group and its affiliates have reported an 8.3% beneficial ownership stake in IDEX Corporation's common stock as of June 30, 2025.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a beneficial ownership of 6.69% of IDEX Corporation's common stock as of March 31, 2025.

Wellington Management Group LLP and its affiliates have disclosed a passive beneficial ownership of 5.57% of IDEX Corporation's common stock as of December 31, 2024.